Page 2 - Positive Implications News Today

Sales success depends on good lead qualification. Check out our in-depth guide to close more sales, exceed your quota, and grow revenue at your company.

Article content The results, announced on May 7, 2021, demonstrate the mechanism of action of ArtemiC™ is to reduce inflammation and suppress the cytokine storm 2 – believed to be the one of the leading causes of mortality in COVID-19 patients 3. The results show that ArtemiC™ decreases the markers of inflammation (IFN-g, IL-1a and TNF-a), in the bronchoalveolar lavage fluid (BALF) of mice in the animal model of cytokine storm related to COVID-19. The clinical and preclinical results to d...